ROBIN KRAUSE: Open Payments
NPI 1659401214 · LORAIN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$549 in 33 payments from 12 companies in 2025. Trend: 2023 $26 · 2024 $372 · 2025 $549
Food & beverage: $549
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $220 |
| E.R. Squibb & Sons, L.L.C. | 5 | $107 |
| ACADIA Pharmaceuticals Inc | 2 | $36 |
| Lundbeck LLC | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 2 | $29 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Indivior Inc. | 1 | $18 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
Products named: VRAYLAR, COBENFY, REXULTI, NUPLAZID, UZEDY, Auvelity, SUBLOCADE, SPRAVATO.
Industry payments across OH — which companies pay providers there.
